Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Predicting tumor recurrence on baseline MR imaging in patients with early-stage hepatocellular carcinoma using deep machine learning.
Kucukkaya AS, Zeevi T, Chai NX, Raju R, Haider SP, Elbanan M, Petukhova-Greenstein A, Lin M, Onofrey J, Nowak M, Cooper K, Thomas E, Santana J, Gebauer B, Mulligan D, Staib L, Batra R, Chapiro J. Kucukkaya AS, et al. Sci Rep. 2023 May 10;13(1):7579. doi: 10.1038/s41598-023-34439-7. Sci Rep. 2023. PMID: 37165035 Free PMC article.
Machine Learning Models for Prediction of Posttreatment Recurrence in Early-Stage Hepatocellular Carcinoma Using Pretreatment Clinical and MRI Features: A Proof-of-Concept Study.
Iseke S, Zeevi T, Kucukkaya AS, Raju R, Gross M, Haider SP, Petukhova-Greenstein A, Kuhn TN, Lin M, Nowak M, Cooper K, Thomas E, Weber MA, Madoff DC, Staib L, Batra R, Chapiro J. Iseke S, et al. Among authors: kucukkaya as. AJR Am J Roentgenol. 2023 Feb;220(2):245-255. doi: 10.2214/AJR.22.28077. Epub 2022 Aug 17. AJR Am J Roentgenol. 2023. PMID: 35975886 Free PMC article.
Reliable prediction of survival in advanced-stage hepatocellular carcinoma treated with sorafenib: comparing 1D and 3D quantitative tumor response criteria on MRI.
Doemel LA, Chapiro J, Laage Gaupp F, Savic LJ, Kucukkaya AS, Petukhova A, Tefera J, Zeevi T, Lin M, Schlachter T, Jaffe A, Strazzabosco M, Patel T, Stein SM. Doemel LA, et al. Among authors: kucukkaya as. Eur Radiol. 2021 May;31(5):2737-2746. doi: 10.1007/s00330-020-07381-9. Epub 2020 Oct 30. Eur Radiol. 2021. PMID: 33123796 Free PMC article.
Thermal ablation alone vs thermal ablation combined with transarterial chemoembolization for patients with small (<3 cm) hepatocellular carcinoma.
Chai NX, Chapiro J, Petukhova A, Gross M, Kucukkaya A, Raju R, Zeevi T, Elbanan M, Lin M, Perez-Lozada JC, Schlachter T, Strazzabosco M, Pollak JS, Madoff DC. Chai NX, et al. Clin Imaging. 2021 Aug;76:123-129. doi: 10.1016/j.clinimag.2021.01.043. Epub 2021 Feb 11. Clin Imaging. 2021. PMID: 33592550 Free PMC article.
MR Imaging Biomarkers for the Prediction of Outcome after Radiofrequency Ablation of Hepatocellular Carcinoma: Qualitative and Quantitative Assessments of the Liver Imaging Reporting and Data System and Radiomic Features.
Petukhova-Greenstein A, Zeevi T, Yang J, Chai N, DiDomenico P, Deng Y, Ciarleglio M, Haider SP, Onyiuke I, Malpani R, Lin M, Kucukkaya AS, Gottwald LA, Gebauer B, Revzin M, Onofrey J, Staib L, Gunabushanam G, Taddei T, Chapiro J. Petukhova-Greenstein A, et al. Among authors: kucukkaya as. J Vasc Interv Radiol. 2022 Jul;33(7):814-824.e3. doi: 10.1016/j.jvir.2022.04.006. Epub 2022 Apr 20. J Vasc Interv Radiol. 2022. PMID: 35460887 Free PMC article.
Comparison of metabolic and immunologic responses to transarterial chemoembolization with different chemoembolic regimens in a rabbit VX2 liver tumor model.
Doemel LA, Santana JG, Savic LJ, Gaupp FML, Borde T, Petukhova-Greenstein A, Kucukkaya AS, Schobert IT, Hamm CA, Gebauer B, Walsh JJ, Rexha I, Hyder F, Lin M, Madoff DC, Schlachter T, Chapiro J, Coman D. Doemel LA, et al. Among authors: kucukkaya as. Eur Radiol. 2022 Apr;32(4):2437-2447. doi: 10.1007/s00330-021-08337-3. Epub 2021 Oct 31. Eur Radiol. 2022. PMID: 34718844 Free PMC article.
15 results